Intra-Cellular Therapies to Present at the 2020 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies, a biopharmaceutical company focused on CNS disorders, announced that CEO Sharon Mates will present at the 2020 RBC Capital Markets Global Healthcare Conference. The presentation is on May 19, 2020, at 9:10 AM ET, and will be accessible via a live and archived webcast on the company's website. Founded on Nobel prize-winning research, Intra-Cellular Therapies develops innovative treatments for complex psychiatric and neurologic diseases.

News Market Reaction – ITCI

+2.70%

+2.70% Session move

In the trading session that priced this news, ITCI gained 2.70%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, May 14, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 2020 RBC Capital Markets Global Healthcare Conference. The presentation is scheduled for Tuesday, May 19, 2020 at 9:10 am ET.

The live and archived webcast can be accessed under "Press Releases & Events" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
jgrimaldi@burnsmc.com
212-213-0006

MEDIA INQUIRIES:

Ana Fullmer
Corporate Media Relations W2Owcg
afullmer@wcgworld.com
202-507-0130

Source: Intra-Cellular Therapies Inc.

FAQ

What is the date and time of Sharon Mates' presentation at the RBC Capital Markets Global Healthcare Conference?

Sharon Mates' presentation is scheduled for May 19, 2020, at 9:10 AM ET.

Where can I watch the presentation by Intra-Cellular Therapies' CEO?

The presentation can be accessed via a live and archived webcast on Intra-Cellular Therapies' website.

What is the focus of Intra-Cellular Therapies as mentioned in the press release?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

Who is the CEO of Intra-Cellular Therapies presenting at the conference?

The CEO of Intra-Cellular Therapies presenting at the conference is Sharon Mates, Ph.D.

What type of company is Intra-Cellular Therapies?

Intra-Cellular Therapies is a biopharmaceutical company specializing in treatments for psychiatric and neurologic diseases.